Würzner R, Mewar D, Fernie B A, Hobart M J, Lachmann P J
Molecular Immunopathology Unit, Medical Research Council Centre, Cambridge, UK.
Immunology. 1995 Jun;85(2):214-9.
The anti-C6 monoclonal antibody WU 6-4 was shown to be unequivocally native restricted since it neither binds to the terminal complement complex (TCC) nor to C5b6. In addition, it was shown to inhibit TCC formation by interfering with C5b6 generation. Using the pUEX expression system and C6 cDNA the WU 6-4 epitope was mapped to the third thrombospondin repeat of C6. This protein domain may therefore contribute to the C5 binding site of C6 and be involved in terminal complement complex assembly. The presence of the epitope in rabbit C6 indicates a useful model for studying inhibition of TCC formation in vivo.
抗C6单克隆抗体WU 6-4被明确证明具有天然限制性,因为它既不与末端补体复合物(TCC)结合,也不与C5b6结合。此外,研究表明它通过干扰C5b6的产生来抑制TCC的形成。利用pUEX表达系统和C6 cDNA,WU 6-4表位被定位到C6的第三个血小板反应蛋白重复序列。因此,该蛋白结构域可能有助于C6的C5结合位点,并参与末端补体复合物的组装。兔C6中表位的存在表明这是一个研究体内TCC形成抑制作用的有用模型。